ACROMEGALY
Clinical trials for ACROMEGALY explained in plain language.
Never miss a new study
Get alerted when new ACROMEGALY trials appear
Sign up with your email to follow new studies for ACROMEGALY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shot could mean fewer injections for acromegaly patients
Disease control Recruiting nowThis study tests a new long-acting medication called Debio 4126 for people with acromegaly, a condition where the body makes too much growth hormone. The drug is given every 12 weeks and aims to keep hormone levels normal. About 119 adults who are already on similar treatments wi…
Matched conditions: ACROMEGALY
Phase: PHASE3 • Sponsor: Debiopharm International SA • Aim: Disease control
Last updated May 26, 2026 04:11 UTC
-
New hope for acromegaly patients: drug may prevent spine fractures
Disease control Recruiting nowThis study looks at two medications for acromegaly, a condition where the body makes too much growth hormone. The goal is to see which drug better prevents spine fractures, a common and painful problem. About 120 adults whose acromegaly is not well-controlled will take either Pas…
Matched conditions: ACROMEGALY
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New hope for acromegaly: experimental drug aims to tame hormone levels
Disease control Recruiting nowThis study tests whether adding a new drug, ALXN2420, to standard acromegaly treatment can better lower a key hormone (IGF-1) linked to the disease. About 60 adults with acromegaly who are already on a stable monthly injection will receive either ALXN2420 or a placebo for 15 week…
Matched conditions: ACROMEGALY
Phase: PHASE2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 07, 2026 18:40 UTC
-
New drug MAR002 takes first step in human trials
Knowledge-focused Recruiting nowThis early-stage study tests whether MAR002 is safe and tolerable in healthy men. The drug is being developed for acromegaly, a condition caused by too much growth hormone. 45 healthy men will receive either MAR002 or a placebo to check for side effects and how the drug moves thr…
Matched conditions: ACROMEGALY
Phase: PHASE1 • Sponsor: Marea Therapeutics • Aim: Knowledge-focused
Last updated May 26, 2026 03:55 UTC
-
10,000 patients help unlock genetic secrets of pituitary tumors
Knowledge-focused Recruiting nowThis study aims to find new genes that cause pituitary tumors, especially in families where the condition runs in the family. Researchers will collect blood and tumor samples from up to 10,000 people with certain types of pituitary tumors, including those with acromegaly or prola…
Matched conditions: ACROMEGALY
Sponsor: Barts & The London NHS Trust • Aim: Knowledge-focused
Last updated May 26, 2026 03:55 UTC